Clinical trial
A Study on the Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
NCT04961450 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study on the Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
- Lead sponsor
- Peking University Third Hospital
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- June 24, 2021
- Completion date
- December 31, 2030
- Enrollment
- 2,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.